Bifidobacterium lactis CECT8145 — A new generation of probiotic strains

All information on this website has not been confirmed by the Department of Health or the FDA, and cannot be used for any medical diagnosis, treatment, prevention of diseases, etc., nor for any commercial use. It is only for academic research purposes, not for general consumption.

Bifidobacterium lactis CECT8145 — A new generation of probiotic strains

Over the last decade, an increasing amount of medical research has focused on the role of weight management and metabolism. Archer Daniels Midland Compnay Biopolis S.L., Spain isolated Bifidobacterium lactis CECT8145 from the faeces of a healthy breast-fed baby and conducted animal and human clinical trials. It found that it has weight management and can also improve skin-related inflammation.

10% stake in Biopolis S.L. is held by the National Spanish Research Council, and Bifidobacterium lactis CECT8145 is a national grade probiotic!

Bifidobacterium lactis CECT8145 efficacy

  • Visceral fat reduction
  • Waist circumference reduction
  • Satiety increase
  • Women’s fat reduction effect is more obvious
  • Hereditary obesity is also effective
  • Strong antioxidant and anti-inflammatory effect

This product features

  • A naturally occurring bacteria
  • Well documented strain
  • Works both alive and heat-killed
  • Favorably tested synergies with other probiotic strains and prebiotics
  • Able to survive intestinal tract (Low pH and Bile salts)
  • Certification : with QPS, GRAS, patents for efficacy, etc.

Copyright is owned by HG BIOMEDICAL Co., Ltd., please do not reprint.